A detailed history of Quantinno Capital Management LP transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Quantinno Capital Management LP holds 121,828 shares of BMY stock, worth $6.55 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
121,828
Previous 161,455 24.54%
Holding current value
$6.55 Million
Previous $8.76 Million 42.22%
% of portfolio
0.09%
Previous 0.19%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$40.25 - $52.99 $1.59 Million - $2.1 Million
-39,627 Reduced 24.54%
121,828 $5.06 Million
Q1 2024

May 14, 2024

BUY
$47.98 - $54.4 $3.78 Million - $4.29 Million
78,786 Added 95.3%
161,455 $8.76 Million
Q4 2023

Feb 14, 2024

SELL
$48.48 - $57.85 $1.76 Million - $2.1 Million
-36,287 Reduced 30.5%
82,669 $4.24 Million
Q3 2023

Nov 14, 2023

BUY
$57.89 - $64.73 $1.39 Million - $1.55 Million
23,998 Added 25.27%
118,956 $6.9 Million
Q2 2023

Aug 04, 2023

BUY
$63.71 - $70.74 $360,152 - $399,893
5,653 Added 6.33%
94,958 $6.07 Million
Q1 2023

May 03, 2023

BUY
$65.71 - $74.53 $312,911 - $354,911
4,762 Added 5.63%
89,305 $6.19 Million
Q4 2022

Feb 13, 2023

BUY
$68.48 - $81.09 $4.02 Million - $4.76 Million
58,644 Added 226.43%
84,543 $6.08 Million
Q3 2022

Nov 07, 2022

BUY
$0.13 - $76.84 $428 - $253,495
3,299 Added 14.6%
25,899 $1.84 Million
Q2 2022

Aug 15, 2022

BUY
$72.62 - $79.98 $487,425 - $536,825
6,712 Added 42.25%
22,600 $1.74 Million
Q1 2022

May 12, 2022

BUY
$61.48 - $73.72 $329,778 - $395,434
5,364 Added 50.97%
15,888 $1.16 Million
Q4 2021

Feb 14, 2022

BUY
$53.63 - $62.52 $564,402 - $657,960
10,524 New
10,524 $656,000
Q1 2019

May 14, 2019

SELL
$45.12 - $53.8 $392,544 - $468,060
-8,700 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$48.76 - $63.23 $424,212 - $550,101
8,700 New
8,700 $452,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $114B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Quantinno Capital Management LP Portfolio

Follow Quantinno Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantinno Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantinno Capital Management LP with notifications on news.